Assessment of Physicochemical Properties of Rituximab Related to Its Immunomodulatory Activity

Figure 6

(a) Serum concentrations of CD20+ B-Lymphocytes measured along the PD study from patients of all groups. (b) Comparison of mean serum concentrations of CD20+ B-lymphocytes from all patients treated with Kikuzubam against the reference product.

(a)

(b)